Search method for inhibitors of staphyloxanthin production by methicillin-resistant Staphylococcus aureus

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 1, 2012, Pages 48-53

  Sakai, Kent ^a   Koyama, Nobuhiro ^a   Fukuda, Takashi ^a   Mori, Yukiko ^b   Onaka, Hiroyasu ^b   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Methicillin resistant Staphylococcus aureus; Microbial metabolite; Screening method; Staphyloxanthin

Indexed keywords

1 DEOXO 1 HYDROXY 8 O METHYLRABELOMYCIN; 6 DEOXY 8 O METHYLRABELOMYCIN; 8 O METHYLRABELOMYCIN; ANTHRAQUINONE DERIVATIVE; ANTIINFECTIVE AGENT; CERULENIN; CIPROFLOXACIN; DIHYDROBISVERTINOL; ERYTHROMYCIN; FARNESOL; HABEKACIN; IMIPENEM; SM 196B; STAPHYLOXANTHIN; STREPTOMYCIN; TETRACYCLINE; TETRANGOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; VIRULENCE FACTOR; XANTHOHUMOL; ZARAGOZIC ACID;

ACTINOBACTERIA; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; IC 50; LIPID METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN;

ACTINOBACTERIA; ALKENES; ANTHRAQUINONES; ANTI-BACTERIAL AGENTS; BENZ(A)ANTHRACENES; BIOLOGICAL AGENTS; CERULENIN; FLAVONOIDS; HETEROCYCLIC COMPOUNDS, 3-RING; LIPID METABOLISM; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PROPIOPHENONES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; XANTHOPHYLLS;

EID: 84855666970     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.48     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb. Mortal. Wkly. Rep., 46, 765-766 (1997).
2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother., 40, 135-136 (1997).
3. Marshall JH, Wilmoth GJ. Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids. J. Bacteriol., 147, 900-913 (1981).
4. Marshall JH, Wilmoth GJ. Proposed pathway of triterpenoid carotenoid biosynthesis in Staphylococcus aureus: evidence from a study of mutants. J. Bacteriol., 147, 914-919 (1981).
5. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med., 202, 209-215 (2005).
6. Clauditz A, Resch A, Wieland KP, Peschel A, Götz F. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect. Immun., 74, 4950-4953 (2006).
7. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science, 319, 1391-1394 (2008).
8. Yamamoto H, Yokoyama H, Simpson K, Nakayama TOM, Chichester CO. Incorporation of 5,10,15 14C-farnesol pyrophosphate into Phycomyces carotenoids. Nature, 191, 1299-1300 (1961).
9. Kuroda M, Nagasaki S, Ohta T. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to beta-lactams in methicillin- resistant Staphylococcus aureus. J. Antimicrob. Chemother., 59, 425-432 (2007).
10. Omura S. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol. Rev., 40, 681-697 (1976).
11. Trifonov LS, Hilpert H, Floersheim P, Dreiding AS, Rast DM, Skrivanova R, Hoesch L. Bisvertinols: a new group of dimeric vertinoids from Verticillium intertextum. Tetrahedron, 42, 3157-3179 (1986).
12. Koyama N, Ohshiro T, Tomoda H, Omura S. Fungal isobisvertinol, a new inhibitor of lipid droplet accumulation in mouse macrophages. Org. Lett., 9, 425-428 (2007).
13. Tobe H, Muraki Y, Kitamura K, Komiyama O, Sato Y, Sugioka T, Maruyama HB, Matsuda E, Nagai M. Bone resorption inhibitors from hop extract. Biosci. Biotechnol. Biochem., 61, 158-159 (1997).
14. Tabata N, Ito M, Tomoda H, Omura S. Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry, 46, 683-687 (1997).
15. Bergstrom JD, Kurtz MM, Rew DJ, Amend AM, Karkas JD, Bostedor RG, Bansal VS, Dufresne C, VanMiddlesworth FL, Hensens OD, Liesh JM, Zink DL, Wilson KE, Onishi J, Milligan JA, Bills G, Kaplan L, Nallin Omstead M, Jenkins RG, Huang L, Meinz MS, Quinn L, Burg RW, Kong YL, Mochales S, Mojena M, Martin I, Pelaez F, Diez MT, Alberts AW. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. Proc. Natl. Acad. Sci. U.S.A., 90, 80-84 (1993).
16. Grabley S, Hammann P, Hütter K, Kluge H, Thiericke R, Wink J, Zeeck A. Secondary metabolites by chemical screening. Part 19. SM 196 A and B, novel biologically active angucyclinones from Streptomyces sp. J. Antibiot., 44, 670-673 (1991).
17. Fotso S, Mahmud T, Zabriskie TM, Santosa DA, Proteau PJ. Rearranged and unrearranged angucyclinones from Indonesian Streptomyces spp. J. Antibiot., 61, 449-456 (2008).
18. Shigihara Y, Koizumi Y, Tamamura T, Homma Y, Isshiki K, Dobashi K, Naganawa H, Takeuchi T. 6-Deoxy-8-O-methylrabelomycin and 8-O-methylrabelomycin from a Streptomyces species. J. Antibiot., 41, 1260-1264 (1988).
19. Dann M, Lefemine DV, Barbatschi F, Shu P, Kunstmann MP, Mitscher LA, Bohonos N. Tetrangomycin, a new quinone antibiotic. Antimicrob. Agents Chemother. (Bethesda), 5, 832-835 (1965).